Patient decision aid based on multi-criteria decision analysis for disease-modifying drugs for multiple sclerosis: prototype development

Table 2. Characteristics of patients (n=13) involved in the alpha testing

		N (%)^a
Gender	Female	10 (77)
Gender	Male	3 (23)
Age (years)	Mean ±SD	53.9 ±9.0
Age (years)	Range	35-64
Highest educational level	Pre-vocational education	3 (23)
	Vocational education	3 (23)
	Higher education	7 (54)
MS type	RRMS	11 (85)
MS type	SPMS	2 (15)
Time since MS diagnosis (in years)	Mean ±SD	17.0 ±11.6
Time since MS diagnosis (in years)	Range	1-38
Experience with DMDs	Yes	13 (100)
Experience with DMDs	No	0 (0)

MS, multiple sclerosis; RRMS, relapsing-remitting multiple sclerosis; SD, standard deviation; SPMS, secondary progressive multiple sclerosis
^aUnless otherwise specified

ISSN: 1472-6947